Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Injections × Clear all

NCT07076095 2025-07-21

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma